Production (Stage)
Omega Healthcare Investors, Inc.
OHI
$36.20
$0.200.56%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 913.17M | 887.91M | 860.23M | 838.94M | 843.98M |
| Total Other Revenue | 171.71M | 163.48M | 151.16M | 138.45M | 130.85M |
| Total Revenue | 1.08B | 1.05B | 1.01B | 977.40M | 974.84M |
| Cost of Revenue | -4.79M | -922.00K | 32.48M | 44.60M | 71.91M |
| Gross Profit | 1.09B | 1.05B | 978.91M | 932.80M | 902.93M |
| SG&A Expenses | 98.53M | 88.00M | 83.97M | 82.50M | 82.51M |
| Depreciation & Amortization | 309.97M | 304.65M | 301.71M | 305.26M | 313.05M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 403.71M | 391.73M | 418.16M | 432.36M | 467.47M |
| Operating Income | 681.17M | 659.66M | 593.23M | 545.04M | 507.37M |
| Income Before Tax | 472.41M | 428.66M | 369.90M | 347.34M | 291.43M |
| Income Tax Expenses | 11.89M | 10.86M | 12.04M | 10.48M | 10.13M |
| Earnings from Continuing Operations | 460.52 | 417.80 | 357.86 | 336.86 | 281.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -12.52M | -11.48M | -9.88M | -9.25M | -7.70M |
| Net Income | 448.00M | 406.33M | 347.99M | 327.61M | 273.60M |
| EBIT | 681.17M | 659.66M | 593.23M | 545.04M | 507.37M |
| EBITDA | 989.98M | 963.16M | 892.60M | 847.09M | 817.10M |
| EPS Basic | 1.63 | 1.57 | 1.38 | 1.33 | 1.12 |
| Normalized Basic EPS | 1.08 | 1.05 | 0.93 | 0.82 | 0.72 |
| EPS Diluted | 1.61 | 1.54 | 1.36 | 1.31 | 1.11 |
| Normalized Diluted EPS | 1.03 | 1.00 | 0.89 | 0.78 | 0.69 |
| Average Basic Shares Outstanding | 1.07B | 1.03B | 1.00B | 986.22M | 973.09M |
| Average Diluted Shares Outstanding | 1.12B | 1.08B | 1.05B | 1.03B | 1.02B |
| Dividend Per Share | 2.68 | 2.68 | 2.68 | 2.68 | 2.68 |
| Payout Ratio | 158.46% | 168.69% | 192.12% | 201.39% | 238.03% |